Monoclonal Antibody Therapy in Treating Patients With Recurrent Hodgkin's Lymphoma

Summary

RATIONALE: Monoclonal antibodies can locate cancer cells and either kill them or deliver cancer-killing substances to them without harming normal cells. PURPOSE: Phase II trial to study the effectiveness of monoclonal antibody therapy in treating patients who have progressive or recurrent Hodgkin's lymphoma.

Timeline

Start

2002-07

Primary completion

—

Completion

2003-04

Drugs

Indications